Fermenta Biotech has announced the successful listing of its equity shares on the National Stock Exchange of India (NSE), marking a milestone in the company's 75-year journey and strengthening its presence in India's capital markets.

Effective August 4, 2026, 29.43 million equity shares with a face value of INR 5 each have been admitted to trading on the NSE under the symbol FERMENTA and ISIN INE225B01021. The company's shares will continue to remain listed on the BSE under Scrip Code 506414.

The milestone was commemorated with a ceremonial bell-ringing event at the NSE's Exchange Plaza in Mumbai's Bandra Kurla Complex. The event was attended by representatives from the NSE, members of Fermenta's Board of Directors, senior leadership and other key stakeholders.

Founded in 1951, Fermenta Biotech has evolved from its pharmaceutical and biotechnology roots into a globally recognised manufacturer of vitamin D3 Active Pharmaceutical Ingredient (API), premium nutritional ingredients, green chemistry products, specialised APIs and customised food premixes. Today, the company serves customers in more than 60 countries, supported by advanced manufacturing capabilities, global quality certifications and regulatory compliance.

The company said the NSE listing complements its long-standing BSE listing, where it has been listed since 1977, and reflects its expanding global footprint and growing investor interest. The dual listing is expected to improve market visibility, enhance liquidity, broaden investor participation and enable more efficient price discovery.

Commenting on the development, Prashant Nagre, Managing Director, Fermenta Biotech, said the NSE listing represents a landmark achievement in a significant year for the company as it celebrates 75 years of operations and nearly five decades as a publicly listed enterprise.

He added that the milestone reflects Fermenta's journey of resilience and continued focus on innovation, scale and operational excellence. The company will continue to strengthen its capabilities across nutrition, food fortification, green chemistry and specialised solutions while enhancing its capital market presence through transparent governance and active shareholder engagement.

Nagre also thanked the company's promoters, Board, employees, shareholders, customers, partners and other stakeholders for their continued trust and support, reaffirming Fermenta's commitment to creating sustainable long-term value.